STOCKSCREENR
Log In

DXRX.L

LSE

Diaceutics PLC

$144.60-1.40(-0.96%)Mkt Cap: $122.32M

Key Stats

Market Cap

$122.32M

P/E Ratio

-72.30

EPS

$-0.02

Dividend Yield

0.00%

52-Week Range

$106.00 — $176.25

Volume

5.03K

Avg Volume

139.77K

Beta

1.04

Valuation

P/E (TTM)

-72.30

Forward P/E

25624.69

PEG Ratio

-3.73

P/S (TTM)

3.59

P/B (TTM)

1.66

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.04%

ROA (TTM)

-0.03%

ROIC

—

Gross Margin

0.86%

Operating Margin

-0.06%

Net Margin

—

Debt/Equity

0.03

Current Ratio

3.96

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-1.03%

EPS Growth (5Y)

-0.52%

Sales Growth (3Y)

+0.32%

Sales Growth (5Y)

+0.20%

EPS Est (This Year)

$0.01

EPS Est (Next Year)

$0.04

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.25

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

84.59M

Float

49.29M

Free Float %

58.27%

About

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

GB

Exchange

LSE

IPO Date

2019-03-21

Employees

184

CEO

Ryan Keeling

Index Membership

—

Website

https://www.diaceutics.com

Diaceutics PLC (DXRX.L) is a healthcare company in the medical - diagnostics & research industry listed on the LSE. With a market capitalization of $122.32M, a P/E ratio of -72.30, DXRX.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare DXRX.L against other stocks using dozens of fundamental and technical filters.

Similar Stocks

PRPO

Precipio, Inc.

$29.35

+6.73%

$51.42M

NEO

NeoGenomics, Inc.

$8.27

+0.36%

$214.71M

0G8X.L

Immunovia AB (publ)

$0.16

-0.37%

$55.28M

MYGN

Myriad Genetics, Inc.

$4.78

+4.14%

$446.97M

EDT.TO

Spectral Medical Inc.

$1.28

+2.34%

$370.10M

SERA

Sera Prognostics, Inc.

$2.01

-2.43%

$75.63M

Frequently Asked Questions

What is Diaceutics PLC's P/E ratio?

Diaceutics PLC (DXRX.L) has a trailing twelve-month (TTM) P/E ratio of -72.30. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Diaceutics PLC pay a dividend?

No, Diaceutics PLC (DXRX.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Diaceutics PLC's market cap?

Diaceutics PLC (DXRX.L) has a market capitalization of $122.32 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.